Nektar Therapeutics (NKTR)
NASDAQ: NKTR · Real-Time Price · USD
30.20
-2.34 (-7.19%)
Nov 20, 2026, 4:00 PM EST - Market closed
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of $1.03 billion as of November 20, 2026. It is the 9,321st most valuable company in the world and the 2,141st biggest in the United States. Its market cap has decreased by 15.83% in one year.
Market Cap
1.03B
Enterprise Value
209.09M
1-Year Change
-15.83%
Global Rank
Country Rank
#2,141 United States
Category
ChartMarket Cap Chart
Since December 1, 1998, Nektar Therapeutics's market cap has increased from $478.60M to $1.03B, an increase of 115.90%. That is a compound annual growth rate of 2.79%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 1.03B | 20.15% |
| Dec 31, 2025 | 860.00M | 401.46% |
| Dec 31, 2024 | 171.50M | 59.09% |
| Dec 29, 2023 | 107.80M | -74.62% |
| Dec 30, 2022 | 424.80M | -82.96% |
| Dec 31, 2021 | 2.49B | -18.24% |
| Dec 31, 2020 | 3.05B | -19.69% |
| Dec 31, 2019 | 3.80B | -33.26% |
| Dec 31, 2018 | 5.69B | -39.50% |
| Dec 29, 2017 | 9.40B | 401.47% |
| Dec 30, 2016 | 1.88B | -16.61% |
| Dec 31, 2015 | 2.25B | 12.95% |
| Dec 31, 2014 | 1.99B | 51.06% |
| Dec 31, 2013 | 1.32B | 54.43% |
| Dec 31, 2012 | 853.40M | 33.30% |
| Dec 30, 2011 | 640.20M | -47.19% |
| Dec 31, 2010 | 1.21B | 39.56% |
| Dec 31, 2009 | 868.60M | 68.99% |
| Dec 31, 2008 | 514.00M | -16.91% |
| Dec 31, 2007 | 618.60M | -54.96% |
| Dec 29, 2006 | 1.37B | -4.78% |
| Dec 30, 2005 | 1.44B | -15.13% |
| Dec 31, 2004 | 1.70B | 122.51% |
| Dec 31, 2003 | 763.80M | 70.57% |
| Dec 31, 2002 | 447.80M | -56.04% |
View and export this data all the way back to 1998. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Ascentage Pharma Group International | 1.10B |
| Alpha Tau Medical | 1.09B |
| Kardigan | 1.08B |
| Jade Biosciences | 1.06B |
| Inhibrx Biosciences | 1.02B |
| SpyGlass Pharma | 1.02B |
| Alto Neuroscience | 1.02B |
| Omeros | 983.66M |